Antiprothrombin antibodies induce platelet activation: A possible explanation for anti‐FXa therapy failure in patients with antiphospholipid syndrome?

BACKGROUND: Arterial and venous thrombosis are both common in antiphospholipid syndrome (APS). Recent studies have shown that anti‐factor Xa (FXa) therapy in APS patients leads to a greater number of patients with arterial thrombosis than with warfarin. We hypothesize that this may be due to the low...

Descripción completa

Detalles Bibliográficos
Autores principales: Chayoua, Walid, Nicolson, Phillip L. R., Meijers, Joost C. M., Kardeby, Caroline, Garcia‐Quintanilla, Lourdes, Devreese, Katrien M. J., de Laat, Bas, Watson, Stephen P., de Groot, Philip G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
PLATELETS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360052/
https://www.ncbi.nlm.nih.gov/pubmed/33774918
http://dx.doi.org/10.1111/jth.15320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360052/
https://www.ncbi.nlm.nih.gov/pubmed/33774918
http://dx.doi.org/10.1111/jth.15320

Ejemplares similares